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ABSTRACT
Objective Promotional media coverage of early detection 
tests is an important driver of overdiagnosis. Following 
research evidence that global media coverage presents 
the benefits of testing healthy people far more frequently 
than harms, and gives little coverage to overdiagnosis, we 
sought to examine journalists’ views on media reporting 
of tests, overdiagnosis, and strategies to improve critical 
reporting on tests.
Design Qualitative study using semistructured telephone 
interviews. Interviews were conducted between February 
and March 2020 and were audiorecorded and transcribed 
verbatim. Framework thematic analysis was used to 
analyse the data.
Participants and setting Twenty- two journalists (mainly 
specialising in health reporting, average 14.5 years’ 
experience) based in Australia.
Results This sample of journalists acknowledged the 
potential harms of medical tests but felt that knowledge 
of harms was low among journalists and the public at 
large. Most were aware of the term overdiagnosis, but 
commonly felt that it is challenging to both understand 
and communicate in light of strong beliefs in the benefits 
of early detection. Journalists felt that newsworthiness 
in the form of major public health impact was the key 
ingredient for stories about medical tests. The journalists 
acknowledged that factors, like the press release and 
‘click bait culture’ in particular, can influence the framing 
of coverage about tests. Lack of knowledge and training, 
as well as time pressures, were perceived to be the main 
barriers to critical reporting on tests. Journalists felt that 
training and better access to information about potential 
harms would enable more critical reporting.
Conclusions Effectively communicating overdiagnosis is 
a challenge in light of common beliefs about the benefits 
of testing and the culture of current journalism practices. 
Providing journalists with training, support and better 
access to information about potential harms of tests could 
aid critical reporting of tests.
BACKGROUND
Advances in early detection testing 
through diagnostic technology, screening 
programmes, biomarkers, artificial intelli-
gence and self- tracking technologies such as 
the Apple Watch are increasingly aimed at 
healthy people to detect a potential disease 
prior to the onset of symptoms.1–5 While 
early detection tests may have benefits for 
those with a potentially serious disease, there 
is considerable evidence that unnecessary 
testing can harm healthy people through 
overdiagnosis.6–8 Overdiagnosis occurs when 
individuals are labelled with a technically 
correct diagnosis that does not improve health 
outcomes.9 10 It is now widely recognised as 
a threat to human health and health system 
sustainability.9 11–16
Many possible drivers of overdiagnosis 
have been documented. The media, through 
promoting early detection tests to healthy 
individuals, is considered an important 
driver.15 A recent cross- sectional study17 of 
global media coverage—including over a 
thousand media stories about five early detec-
tion tests (three- dimensional mammography 
for breast cancer, liquid biopsy for cancers, 
Apple Watch for atrial fibrillation, blood 
biomarker tests and artificial intelligence 
technology for dementia)—found that the 
potential benefits of testing were presented 
far more frequently than potential harms. 
The risk of overdiagnosis was mentioned 
in very few stories. These findings align 
Strengths and limitations of this study
 ► This is the first study to explore Australian journal-
ists’ views on the reporting of medical tests and 
overdiagnosis.
 ► The findings will help inform strategies to improve 
critical reporting on medical tests and communicate 
better about overdiagnosis.
 ► Our sample comprised mainly health- specific jour-
nalists with an interest in taking part in the study 
and may not be representative of all journalists.
 ► It remains unclear if the journalists’ knowledge of 
how to critically report on tests translates into criti-
cal reporting in practice.
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with published studies of media coverage of health and 
medicine, which have found that the media emphasise 
potential benefits more than harms.18–21 The COVID-19 
pandemic—in particular—has brought this problem into 
sharp focus. Many media outlets have hyped the effect 
of anti- viral drugs on the basis of small, industry- funded, 
uncontrolled studies—potentially hampering treatment 
evaluation efforts and responses to the pandemic.22
The media’s often unrealistic and over- optimistic 
expectations about the value of early detection tests 
is a cause for concern for four main reasons. First, the 
general public, and patients, already tend to overestimate 
the benefits of early detection23–25 and uncritical media 
coverage can reinforce these perceptions. Second, few 
individuals seem to be aware of the potential harms of 
early detection and overdiagnosis.26 27 Third, there is 
evidence that tests are already widely overused.28 29 And 
fourth, media coverage can influence patterns of health-
care utilisation—with positive coverage of a test or treat-
ment associated with increases in utilisation30–32 (eg, see 
box 1).
Given the powerful role that the media can play in 
perpetuating the present lack of awareness of the down-
sides of testing, including overdiagnosis, and in shifting 
public health behaviours, strategies to improve media 
reporting of tests and overdiagnosis are needed. While 
there is a considerable scientific literature on how the 
media frames different health issues, less attention has 
been given to hearing journalists’ perspectives on media 
coverage of medical tests and overdiagnosis. To our knowl-
edge, one qualitative study33 has previously examined US 
journalists views of media coverage of overtreatment. The 
sample of journalists in this study nominated overtesting 
(eg, cancer screening) as an important driver of over-
treatment. However, no study has examined journalists’ 
specific perspectives of new tests, and their benefits and 
harms. This study sought to redress this knowledge gap.
METHODS AND ANALYSIS
Study design
This qualitative study used semistructured telephone 
interviews to explore journalists experience of, and atti-
tudes to, reporting on medical testing, overdiagnosis and 
strategies to improve media coverage of both tests and 
overdiagnosis. It was designed and reported according 
to the Consolidated Criteria for Reporting Qualitative 
Research.34 See online supplemental file 1 for the study 
protocol.
Participants and recruitment
Participants were 22 Australia- based journalists. Both 
health journalists and generalist journalists across any 
type of media were included. To be eligible, partici-
pants needed to be currently working as a journalist 
in Australia, be able to communicate in English (both 
orally and in written form) and be able to give informed 
consent. Ability to read and understand English were key 
inclusion criteria for the study because the interview was 
conducted in English. There were no restrictions on the 
age or gender of participants.
Journalists were purposively recruited through three 
different avenues: (1) There was journalism expertise 
in the author team (RM) and personal contacts played 
a role in the initial development of a list of potential 
participants to contact; (2) One author (MO) performed 
Google and Twitter searches to locate potentially eligible 
journalists. If a journalist had publicly available contact 
information, they were emailed about the study and; (3) 
Active ‘snowball’ recruitment was used by asking partici-
pating journalists to suggest other eligible journalists they 
believed would be interested in being involved.
All potential participants were emailed a participant 
information sheet outlining aims and important infor-
mation about the study. Those interested in taking part 
returned a consent form to researchers through email 
and were contacted to arrange an interview.
Data collection
An interview schedule (online supplemental file 2) was 
developed, discussed and piloted by the research team. 
The research team have expertise across public health 
(MO, BN, TD, CM, LA, KM and AB), epidemiology (AB 
and LA), psychology (KM), health communication (MO, 
BN, KM and AB), overdiagnosis (MO, BN, TD, LA, CM, 
KM, AB and RM) and journalism (AB and RM). The tele-
phone interviews were conducted by four researchers 
(MO, BN, TD and RM) between February and March 
2020. Interviews lasted approximately 45 min, and were 
audiorecorded and transcribed verbatim. The inter-
viewers took notes during the interviews to highlight key 
themes emerging from the interviews and direct further 
questioning (eg. explore a point raised by the journalist). 
This information enabled the interviewer to summarise 
back to the journalist at the end of the interview and give 
them an opportunity to provide further information.
Data analysis
The interview data were analysed using Thematic Frame-
work Analysis. Microsoft Excel was used to organise the 
data to capture the views expressed by the journalists. 
The first step was familiarisation of the data, where one 
researcher (MO) independently reviewed the transcripts 
Box 1 The power of the media
 ► Media coverage of Kylie Minogue’s breast cancer diagnosis in 
Australia in May 2005 led to a 20- fold increase in media coverage 
about breast cancer, with a particular emphasis on how young wom-
en can get breast cancer and the importance of early detection.32
 ► Bookings for mammograms as part of government- sponsored 
BreastScreen programmes across Australia rose 40% during the 2 
weeks of the coverage, and there was a 101% increase in non- 
screened women in the eligible age group (40–69 years). Six weeks 
after the coverage, bookings stayed more than a third higher in non- 
screened women.32
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and developed a list of emerging themes arising from 
the transcripts. Those themes along with the inter-
view schedule (online supplemental file 2) formed the 
structure of the coding framework. An additional three 
researchers (BN, TD and RM) then read a subset of tran-
scripts and reviewed the coding framework and necessary 
changes or additions to the framework were discussed 
and made. Once the coding framework was finalised, 
one researcher (MO) coded all of the interviews into 
the coding framework, and an additional researcher 
(BN) independently double- coded a random 20% of the 
interviews. Differences in the coding between the two 
researchers were discussed and resolved.
Patient or public involvement
Patients or the public were not involved in the design, 
or conduct, or reporting, or dissemination plans of our 
research.
RESULTS
Journalist characteristics are shown in table 1.
The results of the analysis of the interview data are 
organised around seven main themes: (1) Readers’ 
interest in medical tests; (2) Ingredients of a ‘good’ 
news story; (3) Journalists’ knowledge of potential harms 
of medical tests; (4) Factors influencing the framing of 
media coverage on tests; (5) Barriers to critical coverage 
of medical tests; (6) Enablers of critical coverage of 
medical tests and; (7) Interest in a training intervention. 
See online supplemental file 3 for extra journalist quotes 
relating to each theme.
Readers’ interest in medical tests
The vast majority of journalists felt that stories about 
medical tests are popular among readers, particularly 
where the test relates to a common or serious health 
condition, like cancer and inheritable conditions.
“the concept of being able to detect disease in someone who 
might be unknowingly walking around with a ticking time 
bomb in their chest or blood stream is really compelling” (J7, 
6 years’ experience)
The public’s enthusiasm for technology to catch a 
health issue early was mentioned by some journalists.
Ingredients of a ‘good’ news story
Public health impact was deemed the most important 
ingredient for reporting on a test by most journalists. 
Impact was frequently explained in terms of positive 
changes in the management of a common condition.
“how big is this step forward or, you know, how soon will it 
be introduced to patients, or practically speaking what does 
it change for them … so I guess always having that patient 
lens in mind.” (J22, 3 years’ experience)
Peer- reviewed research as a prerequisite for reporting 
on a medical test was acknowledged by the vast majority 
of journalists. Very few elaborated on the importance of 
the quality of the research (eg. the likelihood of bias). 
Many journalists said they seek independent comment 
Table 1 Journalist characteristics
Characteristics
No of journalists 
(n=22)
Type of journalist
  Health 14 (63.6%)
  Science (including health) 6 (27.3%)
  General 2 (9.1%)
Gender
  Male 4 (18.2%)
  Female 18 (81.8%)
Years of experience
  <5 3 (13.6%)
  5–10 9 (40.9%)
  11–20 2 (9.1%)
  21–25 2 (9.1%)
  >30 6 (27.3%)
Workplace setting
  The Australian Broadcasting Corporation 
(ABC)
8 (36.4%)
  Freelance 6 (27.3%)
  Online and print newspaper (Sydney Morning 
Herald)
3 (13.6%)
  Health website (Medical Republic) 2 (9.1%)
  Not- for- profit media outlet accepting stories 
from academics (The Conversation)
2 (9.1%)
  Online newspaper (New Daily) 1 (4.5%)
  Peer- reviewed journal (Medical Journal of 
Australia)
1 (4.5%)
Level of health story reporting
  A lot (writes health articles on most days) 18 (81.8%)
  Some (every second week) 2 (9.1%)
  Very little (less than once a month) 1 (4.5%)
History of reporting on medical tests
  Yes 16 (72.7%)
  No 4 (18.2%)
  Unsure 2 (9.1%)
History of training in understanding medical evidence
  Yes 7 (31.8%)
  No 15 (68.2%)
Approached to report on medical tests
  Yes 15 (68.2%)
  No 7 (31.8%)
The ABC provides radio, television and online services. The majority of 
ABC employed journalists in this study perform online and radio roles. 
The participants from The Conversation and The Medical Journal of 
Australia are journalists/editors who select, steer and edit news stories 
and submitted articles. They have former roles in mainstream media.
Most of the journalists were based in major population regions such as 
Sydney, Melbourne, Gold Coast and Perth.
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on tests from trustworthy sources like a university, and 
some journalists said they would seek clarification on 
vested interests before reporting on a test. Four journal-
ists explicitly said they would ask about vested interests, 
including financial gain from promoting and/or selling 
the test.
Knowledge of potential harms of medical tests
The vast majority of journalists acknowledged the poten-
tial harms of medical tests, and mostly referred to the 
harms of screening for prostate and breast cancers, 
such as unnecessary testing, unnecessary treatments and 
anxiety. All journalists except one were aware of the term 
overdiagnosis. A few had a deeper understanding.
“Like my understanding of that is that you often will have 
people diagnosed with something, and they know they’ve got 
it but it’s not going to actually affect them. If they’d never 
had the test they would never have known and they’d have 
lived a happy healthy life.” (J13, 6 years’ experience)
Most journalists felt that knowledge of harms was 
low among the public and journalists in general due 
to frequent exposure to messaging about the benefits 
and importance of early testing. Several journalists felt 
that overdiagnosis was a difficult concept for readers to 
understand.
“I think generally there appears to be an attitude, certainly 
in a country like Australia, that public health screening is 
a very important public health measure. And that the more 
screening you do, the better. You know, I can’t remember a 
campaign ever that was trying to get people to not go to the 
doctor (laughs)” (J6, 6 years’ experience)
Only a small number of journalists viewed it as impor-
tant to get information on safety concerns or potential 
side effects of a test before writing a story.
Factors influencing the framing of media coverage
The power of the press release to influence coverage was 
acknowledged by most journalists. A small number of 
journalists suggested that a journalist’s control over using 
the press release may be low depending on overall priori-
ties for news content within the organisation.
“It’s like here’s the story, here’s the new product, here’s the pa-
tient, his life has been saved or changed or altered. You know, 
here’s how many people it’s going to save, here’s our expert. 
You know, it’s a real parcel.” (J1, 20 years’ experience)
Click bait (sensationalised titles designed to attract 
readers to click on stories) was mentioned by most jour-
nalists and was perceived to have downsides. However, a 
few journalists acknowledged that click bait can be driven 
by systemic issues which may be hard to modify. These 
include attempts to keep content interesting and obtain 
funding.
“if you can get a big headline out of it, if you can turn it into 
click bait, all the better. And I think that’s the danger. I mean 
I saw something the other day about some cancer test that’s 
going to be a breakthrough, and it had only just, you know, 
made it to rat trials.” (J8, 32 years’ experience)
Most journalists acknowledged the potential for 
commercial interests to influence the media coverage of 
tests. About half of the journalists commented on a lack 
of training and experience, particularly among young 
generalist journalists, as a contributor to the framing 
of media coverage. A minority of journalists stated that 
many journalists are tempted to report very good or very 
bad news as it was felt that extremes in news coverage are 
more attractive to readers.
Barriers to critical coverage of medical tests
Lack of knowledge and experience of the medical 
evidence and harms was perceived to be the biggest 
barrier to improving coverage on medical tests by most 
journalists. Knowledge was generally in relation to reading 
research, and knowing the right questions to ask (eg. 
about commercial interests). Some journalists said that 
lack of knowledge and experience was compounded by 
the reduction in the number of specific health journalists.
“When it comes to screening tests, I would say the knowledge 
around the potential pitfalls of screening or over screening 
is not well known or understood. I think that applies to the 
general population but I also think that probably applies to 
journalists as well.” (J6, 6 years’ experience)
Most journalists mentioned time pressure as a signif-
icant barrier to critical reporting and often stated they 
themselves were fortunate to have time available to 
research a story.
Several journalists stated that access to trustworthy 
experts for independent comment was a real problem 
for their reporting. If a press release did not come with 
an independent comment, journalists often lacked 
the time to find one. Some felt it was difficult to access 
experts on certain health topics. Researcher availability 
was also mentioned as an issue. Specifically, it was difficult 
to speak with certain researchers as they may not answer 
calls/emails.
A small number of journalists said they tended to feel 
uncomfortable talking about harms including overdiag-
nosis as they can be difficult to communicate, and have 
potential to provoke unpleasant emotions in people who 
may be affected by a health condition (eg, cancer).
“I tend to be a bit hesitant to report on the dangers of over-
testing and overdiagnosing when the proponents of these 
tests have such powerful and personal stories to tell.” (J7, 6 
years’ experience)
Enablers of critical coverage of medical tests
The provision of journalist training was viewed as 
important to improve the critical coverage of tests by 
most journalists. They felt training should mainly focus 
on learning how to critically appraise research and press 
releases, understand statistics, and knowing the questions 
to ask about a test.
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“A basic understanding of what the different levels of evi-
dence are, what kinds of studies there are and why some are 
better than others about making strong conclusions. I think 
some statistics would help, if only just the basics of you know, 
absolute vs relative, and P scores and stuff like that. I think 
knowing, if we can train them about the downsides. They 
need to ask every single time, what are the downsides? And I 
don’t think people do.” (J8, 32 years’ experience)
Some journalists felt it was important for institutions 
like universities or government agencies to improve the 
quality of communication of the evidence. Common 
suggestions were improving press release quality to 
include conflict of interests and funding, and avoiding 
overstatements of findings.
Most journalists felt that researchers and national 
bodies (eg. Cancer Council) need to better communicate 
the harms of testing to journalists. This includes initiating 
stories, providing information about harms, as well as 
listing harms on websites where readers could find out 
more.
Interest in a training intervention
All journalists expressed an interest in training. The jour-
nalists were quite evenly split in terms of preferences for 
face- to- face, online or combined face- to- face and online 
training. All journalists highlighted the importance of 
keeping the training short in duration and most liked the 
idea of resources and ongoing support. Frequent sugges-
tions were checklists, access to expertise for comment, 
fact- checking and reminders.
“And then I also think that a resource that would be useful, 
something you can take away like an at a glance kind of 
‘don’t forget these five things’. Something that’s, they can then 
sort of stick on their desk…” (J13, 6 years’ experience)
DISCUSSION
Summary of key findings
The findings from this interview study suggest that 
many journalists may be aware of the potential harms of 
medical tests such as overdiagnosis, but they commonly 
view information about harms as difficult to access and 
communicate. Knowledge of harms such as overdiag-
nosis, however, was perceived to be low among the public 
and journalists at large yet important and interesting. In 
particular, overdiagnosis was viewed as a counterintuitive 
concept for many, given prominent public health efforts 
to promote the benefits of early detection. The journal-
ists identified a number of factors that influence coverage 
and present challenges to improving critical reporting on 
tests. Journalists were engaged by the idea of receiving 
training and support.
Comparison to existing literature
Our findings align with a number of other qualitative and 
survey studies of journalists that newsworthiness, time 
pressures, click bait and a lack of medical knowledge are 
important factors in both influencing media coverage of 
health topics and attempts to change coverage.35–38 Views 
on the power of the press release are supported by quan-
titative data showing that the quality of the press release 
is associated with the quality of the subsequent medical 
news reporting,39 40 and that journalists frequently rely 
on press releases for story ideas.41 The problems with 
press releases have been highlighted again during the 
COVID-19 pandemic through the media’s reliance on 
potentially unreliable preprints, or preliminary or partial 
results promoted before peer review, to communicate 
treatment effectiveness.22
The prevalence of click bait in media coverage fits 
broadly with cross- sectional studies displaying the media’s 
frequent use of emotive words like ‘breakthrough’, 
‘revolutionary’ and ‘unprecedented’ to report new treat-
ments.42 43 In fact, one randomised trial found that use of 
words like ‘breakthrough’ and ‘promising’ in reference 
to medicines in media releases increases the public’s 
belief in drug effectiveness compared with facts- only 
explanations.44
The observation that promotion and desire for early 
detection testing is widespread fits with the consider-
able literature displaying public, patient, and clinicians’ 
beliefs in the benefits of testing.22 23 45 In a qualitative 
study33 examining US journalists views of media coverage 
of overtreatment, the sample of journalists viewed the 
issue of overtreatment—together with overtesting— as a 
complex matter driven by strong public faith in health-
care and societal norms that make medical uncertainty 
difficult to accept. Further, there is data showing that 
medical marketing of tests to persuade individuals about 
the importance of early detection is escalating.46 The 
journalists’ need for access to better information and 
expertise aligns with previous qualitative work.35 37
Strengths and weaknesses of this study
To our knowledge, this is the first study to explore jour-
nalists’ views on media reporting of medical tests and 
the problem of overdiagnosis. This study provides useful 
information about the barriers to critical reporting on 
tests, and enablers which could improve it. The find-
ings will facilitate the development of strategies to better 
support journalists to report on the harms of tests, 
including overdiagnosis.
The study has some important limitations. A highly 
selective sample of journalists was included. Only 
Australia- based journalists were included. Although we 
approached journalists of various levels of experience and 
from different types of media outlets, the majority of the 
sample were experienced health journalists working for 
well- regarded media outlets. These journalists expressed 
awareness of overdiagnosis. This may be influenced by 
our recruitment strategies and journalists’ willingness to 
participate in this specific research. The generalisability 
of the results may be limited for journalists in different 
countries with a different media landscape or less experi-
enced reporters who do not specialise in health reporting.
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Meaning of the study
The finding that journalists are very interested in receiving 
research training and support should be welcomed by 
researchers and organisations interested in improving the 
critical reporting of tests and knowledge of overdiagnosis. 
Journalists are well positioned to educate the public about 
medical tests31 47 and media coverage of tests can influ-
ence healthcare utilisation.30 32 The media have contrib-
uted to improvements in health- related knowledge and 
behaviours—for example, in the areas of low back pain, 
smoking cessation and vaccination.48–50 Improving critical 
reporting on early detection could encourage more real-
istic expectations about the benefits of early detection and 
an awareness of potential harms such as overdiagnosis.7 
Future research should focus on developing training and 
resources for journalists and examining their impact on 
journalist knowledge and the quality of media coverage 
on tests. This research should build on previous work-
shops and tipsheets for journalists (eg. The US National 
Institutes for Health Medicine in the Media workshops by 
Drs Lisa Schwartz and Steven Woloshin,47 51 and available 
checklists of medical reporting criteria for journalists (eg, 
those available from Media Doctor Australia and  Health-
NewsReview. org).
Journalists face numerous challenges. First, the public 
has long received the message that early detection is a 
good thing. Second, the complexity of overdiagnosis and 
uncertainty in the evidence base may together make it 
difficult to communicate the nuances involved. Third, 
journalists must grab the readers’ attention by providing 
interesting stories within tight deadlines. There are oppor-
tunities for academics and organisations to understand 
these working environments and be available to commu-
nicate stories in an engaging but accurate manner. Finally, 
interventions should not only target journalists, but also 
the wider levers (eg. press releases) that contribute to 
how information about medical tests is communicated.
CONCLUSION
This sample of Australian journalists seem aware of the 
potential harms of medical tests such as overdiagnosis, 
which are often left out of media coverage.17 But, effec-
tively communicating overdiagnosis is a challenge in light 
of entrenched beliefs about the benefits of testing and 
the culture of current journalism practices. Providing 
journalists with training and support in their efforts to 
communicate overdiagnosis could aid critical reporting 
of tests. This may contribute to addressing the wider 
problem of medical test overuse, which is a major threat 
to health system sustainability.
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Early detection of disease is gaining considerable attention worldwide.1 Enthusiasm for early 
detection is displayed by the increasing interest in advances in diagnostic technology, screening 
programmes, innovations in biomarkers,  and “P4 medicine” (predictive, preventive, 
personalised, and participatory).1-3 In fact, testing in medicine is increasingly aimed at 
apparently healthy people to identify those at an increased risk of a disease or disorder.4 This 
communicates one message: early detection is a good thing.1  
 
However, there is mounting evidence that unnecessary and/or excessive testing can harm 
healthy people, and the quest for ever-earlier detection of disease can lead to overdiagnosis. 
Overdiagnosis happens when people are diagnosed in ways that do not benefit them or that can 
do more harm than good.5,6 Although an exact definition of overdiagnosis remains the subject 
of debate, particularly in the context of non-cancer conditions, overdiagnosis can be considered 
to occur when persons are labelled with a technically correct diagnosis that does not improve 
health outcomes.7,8  Overdiagnosis is a major global challenge to health system sustainability 
and human health and strategies to reduce overdiagnosis are urgently needed.9  
 
Many possible drivers of overdiagnosis have been documented.9 One major driver is the 
promotion (to clinicians and the public) of increasingly sensitive tests.9 These can lead to 
detection of “abnormalities”, which may be of uncertain clinical significance. Tests being 
increasingly promoted to the healthy include the Apple Watch for the early detection of atrial 
fibrillation, liquid biopsies and artificial intelligence for the early detection of cancer and 
Alzheimer’s disease, and 3D mammography for the early detection of breast cancer.4 Poor 
quality  media reporting has been highlighted as a strong driver of this promotion.9  Uncritical 
media coverage of the benefits and breakthrough of new tests, without consideration of their 
potential downsides or harms, potentially contributes to a more general lack of awareness about 
the potential harms of getting tested when healthy. In fact, research has shown that only a small 
proportion of people are knowledgeable about overdiagnosis.10 Further, patients (and 
clinicians) overestimate the benefits of testing, while underestimating the harms.11,12 Given the 
powerful role that media can play in influencing public health beliefs and behaviours, strategies 
to improve media reporting of medicine are needed.9 
 
There are concerns that biased media reporting may be exacerbated by the increasingly 
changing media landscape, such as the rising influence of social media and the decline of the 
traditional consumption patterns of mainstream news media.13  With the development of a more 
fragmented media context there is the increasing diminution of the role of specialist reporters 
with resulting loss of baseline technical knowledge, gatekeeping and thoughtful, investigative 
health journalism.13 This presents a major challenge to the communication of complex concepts 
like overdiagnosis. Indeed, previous studies on the media have identified evidence of 
exaggeration,14,15 inaccurate media coverage of published scientific papers,16,17 overstating of 
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benefits of treatments, downplaying of harms14,18 and failure to report important conflicts of 
interest of the experts cited in the story.18  
Poor media coverage of medicine is not an insignificant issue; it can influence how the public 
perceives the risk of health services and how patients make treatment decisions.4 For example, 
media coverage about the celebrity Kylie Minogue's self-referral mammogram bookings led to 
a 20-fold increase in media coverage about breast cancer and a 40% increase in mammogram 
bookings during the 2-week peak after the interview. Six weeks later media coverage was still 
up by 30%.19  
 
While much research has examined how the media frames different health issues, very little 
research has examined the experiences of journalists and attempted to identify obstacles that 
hinder journalists from higher quality reporting, and elucidate possible strategies for addressing 
these. Further, no study has yet examined journalists knowledge and views about the increasing 
problem of overdiagnosis and what this may mean for media reporting of medicine. Also, many 
media outlets are inundated with sometimes conflicting health information from companies, 
researchers, institutions, the government and consumers and it would be interesting to explore 
how they deal with this deluge of information. Furthermore, there is little or no specialised 
training available for journalists who are expected to interpret often complicated statistics like 
relative and absolute risks. While there are guidelines available for journalists on how to 
responsibly report on health matters, journalists have received very little support in the 
implementation of these guidelines.  
 
It is very important to examine the experiences and perceptions of journalists regarding medical 
reporting in a time of increasing recognition of the threats from overdiagnosis and too much 
medicine more generally.  Identifying barriers and potential solutions to good medical 
reporting will help inform the development of an intervention to improve both journalists’ 
confidence and capacity to report more responsibly on medical tests and/or treatments and the 
problem of overdiagnosis. 
 
This project aims to explore journalists’ views on media reporting of medicine (particularly 
medical tests), and barriers and solutions to improving media reporting in a time of 
overdiagnosis and too much medicine. 
 




We will seek ethical approval from the University of Sydney Human Research Ethics 
Committee. 
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Study design  
We will conduct a qualitative study using semi-structured face-to face (or telephone as 
applicable) interviews. Individual interviews will be conducted to allow participants to speak 
in confidence about their views and experiences, and to ensure they are not influenced by other 
journalists with different levels of experience or that work in different settings/specialities. This 
study will be designed and reported according to the Consolidated Criteria for Reporting 




We will recruit 15-20 Australia-based journalists. We will purposively recruit journalists with 
different characteristics (e.g. type of media- TV, print, social media) and levels of experience 
(e.g. years active, speciality). Both specialist medical journalists and non-medical journalists 
will be included. Examples of potential media organisations include the Guardian, News Ltd, 
ABC, Nine-Fairfax, Nine-TV (or 7 TV), and The Conversation.   
To be eligible, participants need be currently working as journalist in Australia, be able to 
communicate in English (both orally and over email), and be able to give informed consent. 
Ability to read and understand English are key inclusion criteria for the proposed study because 





We will recruit potential participants through a number of different avenues, where needed. 
There is journalism expertise in the author team (Ray Moynihan) and personal contacts will 
play a role in the initial development of a list of potential participants to contact. From here we 
will use an active ‘snowball’ recruitment technique by asking participating journalists to 
suggest other eligible journalists they believe would be interested in being involved. We will 
then access their publicly available contact information to approach them about the study. If 
needed, the Australian Science Media Centre and Cochrane Australia will be asked to support 




Interviews will be conducted face-to-face at Sydney School of Public Health (The University 
of Sydney), or via Skype/Zoom/telephone if the participant prefers, by a researcher with 
experience in conducting qualitative interviews. An interview schedule will be developed and 
discussed among the team members. Interview questions will address the following topics: 
journalist background, journalist training, interest in reporting on health and medicine, positive 
and negative experiences of reporting on health and medicine, definition of scientific quality 
in reporting, views on the changing media landscape, knowledge of overdiagnosis and too 
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much medicine, barriers to quality reporting of medical tests, solutions for improving media 
reporting of medical tests, openness to a training intervention and views on the content of an 
intervention package.  
Interviews will last ~60 minutes and will be audio-recorded and transcribed verbatim for 
analysis. The interviewer will also take notes during the interview to highlight key themes 
emerging from the interview and direct further questioning (e.g. explore a point raised by the 
participant). This information will also enable the interviewer to summarise back to the 





The interview data will be analysed using thematic framework analysis. Framework analysis 
is a well-accepted method for analysing qualitative data from interviews and is conducted in 5 
stages. Stage 1 (familiarisation): the interview will be transcribed verbatim (from audio 
recordings) by the researcher who conducted the interview. Stage 2 (identifying a thematic 
framework): transcripts and interview notes will be analysed numerous times to identify codes 
that could be linked together by related concepts. A second researcher will double code half of 
the transcripts to check for reliability of the framework. Disagreements will be resolved 
through discussion. Concepts will then be grouped into broader themes and sub-themes. Stage 
3, 4 & 5 (indexing, charting and mapping, interpretation): data will be summarised and charted 
using Microsoft Excel, and the mapping of themes and sub-themes will be iterative. This 
analysis will be conducted primarily by one researcher, with input from the research team in 
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Supplementary File 2: Journalist Interview Schedule  
 
Thank you very much for doing this interview. As mentioned in the information sheet I sent 
you, this interview is to better understand Australian journalists’ views towards media 
reporting of new medical tests. This interview will take between 30 minutes and one hour.   
 
As mentioned in the participant information sheet, this interview will be audio-recorded to 
make sure we have an accurate record of your responses, and your identity and everything 
you say will be kept strictly confidential.  
 
Do you have any questions before we begin?  
Okay, so I will start the audio-recording now.   
  
 
Journalist experience  
 
• Who/where are you currently working for and what is your current role?  
 
• Have you worked elsewhere in the past?  
[If yes], could you tell us about your previous experience (e.g. where, main role, etc) 
 
• How long have you been active as a journalist?  
 
• General or specialist? 
 
• Health only or not?  
 
• [If general], could you give us a sense of how often you report on a health-related 
topic?  
 
Promotion of new tests 
 
Briefly define what we mean by medical tests before we begin questions.  
There are different forms of medical tests, and we can put them into two broad categories; 
diagnostic tests and screening tests. Diagnostic tests are for people with symptoms to 
diagnose for a specific condition or disease.  For example, something like a new heart scan to 
detect a heart attack, in people reporting symptoms that look like a heart attack.  
But then there’s also screening tests, which are for people without symptoms to try to detect 
disease before, it appears symptomatic. For example, the PSA test for healthy men to 
detect prostate cancer.  
 
• In general, how interested are readers in stories about medical tests?  
• Are you approached about studies on new tests? 
• Have you even been asked to write a story to promote a new test? 
- Who by? 
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• In your view, what are the potential downsides or negative effects of promoting new 
medical tests?   
Prompts if needed: e.g. people overestimating the benefits of new tests, not aware of 
potential downsides or harms of new tests, enthusiasm for tests before there is 
evidence to support their use.  
For example, we did a study examining how the global media reports on the benefits 
and harms of 5 new medical tests for people without symptoms. These were the Apple 
watch ECG, 3D mammography, and blood biomarker and AI tests for dementia and 
cancer. We found that less than 20% of the stories mentioned potential harms or 
downsides of these medical tests. 
 
• There is some concern that uncritical reporting of new medical tests could promote 
overdiagnosis and overtreatment.  
 
• Have you heard of overdiagnosis ?  
o If yes, could you tell me what you understand it to mean?  
 
Prompt example – if needed  
o Overdiagnosis happens when someone gets a diagnosis that ends up causing them 
more harm than good. For example, the apple watch now has an electrocardiogram to 
track heart rhythms in healthy people. It aims to detect a condition called atrial 
fibrillation. The difficulty is that healthy people can have seemingly irregular heart 
rhythms that may never go on to give them any trouble. However, a diagnosis of atrial 
fibrillation may lead to harms from over testing, anxiety due to have a heart condition, 
and bleeding from unnecessary blood thinning medicines.  
 
o Have you reported on it before? What was the context? 
 
• What are your views on overdiagnosis? 
 
• What are your views on how media coverage of new tests, or medicine generally, may 
help to contribute to overdiagnosis?  
 
 
Potential Barriers to reporting accurately on new medical tests 
 
• What do you think are/may be the key challenges or barriers for journalists in 
reporting accurately on new tests?  
Prompts – if needed: 
o Less journalists? 
o Less specialist reporters? 
o Time? 
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• What do you think of an Australian Science Media Centre workshop on this issue? 
A short one- running between 60 and 90 minutes? 
  
• What are relative merits of a workshop that comes to your workplace – like the 
Science Media Centre currently does – compared to a workshop held somewhere- 
that journalists from different media outlets could attend?  
  
• What do you think of the idea of being offered access to a network of researchers 
working in this field? to read a paper, fact check a story for example. 
  





Now we’re coming to the end of the interview, but before we wrap up do you have any 
questions or is there anything, we didn’t discuss that you would like to add in relation to 
journalists reporting new medical tests or overdiagnosis generally? 
 
 
Finally, before we finish, I am wondering do you know of any other journalist(s) who may be 
interested in taking part in this study? We are trying to recruit 10 more journalists. Any 
suggestions would be great.                                                  
 
 
Thank you very much for your time. 
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Supplementary File 3: Journalists quotations 
 
Themes  Supporting quotes  
1. Readers’ interest in tests “Readers are really interested in it. It presents I guess hope and different scientific advances that might 
change outcomes are probably pretty appealing to a general audience.” (J19, 7 years’ experience) 
“I think they’re very interested.‘Cause I think health stories in general are quite popular.‘Cause they 
affect everybody.” (J20, 33 years’ experience) 
2. Ingredients of a ‘good’ news story 
Newsworthiness “Well for starters it needs to, to be a useful test. Like there needs to be a need for it.” (J7, 6 years’ 
experience) 
“Is this delivering something that’s going to be genuinely helpful to people.” (J11, 4 years’ experience) 
Research Evidence “Um… well it’s rarely a randomised trial. The evidence is usually… um… pretty lousy. More often than 
not I won’t do the story.” (J9, 36 years’ experience) 
“I mean reviews are the best but that’s probably, they probably don’t exist for newish testing. yeah, I 
mean I, I guess peer review research, published research” (J19, 7 years’ experience) 
Obtain Independent Opinion “Oh, I’d probably be happy if I’d spoken to a radiologist or a radiation oncologist and a urologist, I 
suppose. It’s a bit of a vexed area where like, you know, it’s been under battle for quite a while. So I’d 
be careful about who I was speaking to I suppose.” (J16, 9 years’ experience) 
“We would go to get some independent comment from someone else not affiliated with the study” (J12, 
30 years experience) 
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Awareness of Vested interests “We want to know where any funding has come from.” (J17, 12 years experience) 
“Who is promoting it? if there’s invested interest, that’s the main thing I can think of.” (J21, 4 years’ 
experience) 
Clarify Safety information “And then you would have a reasonable idea of what, of its efficacy and of course of its safety. And 
they’re the, they’re the two questions that you’re kind of obliged to ask really, you know? Does it work? 
And to what extent does it work? And, is it safe?” (J11, 4 years’ experience) 
3. Journalists’ knowledge of potential harms of medical tests 
General knowledge of harms “It can lead to inappropriate, um, healthcare, inappropriate use of resources or just public resources 
generally. You know, it can lead to over-medicalisation for things.” (J20, 33 years’ experience) 
“All that’s screening. And, um, there are harms as well as benefits. You know, not many harms, but… 
they’ve, they’ve not been well documented.” (J9, 36 years’ experience) 
Knowledge of overdiagnosis “Back pain’s a great example of this, right? If the more people you test, the more abnormalities you 
will find but those abnormalities are actually perfectly natural and aren’t linked to back pain. But once 
you start finding them then it gets into people’s heads that, oh my God their spine’s falling to bits and 
they should be treated and we should do something about it. And so you end up with over treatment as 
well.” (J15, 5 years’ experience) 
“My understanding is that it’s basically, the idea that people are being told that they have illnesses or 
they’re falling into the classification of having a disease or illness, which would otherwise not affect 
their quality of life. And then they may be offered or sold, treatments that aren’t going to make a 
difference because the illness was never going to affect their quality of life in the first place. And then 
the negative obviously of that is that some of these invasive tests and treatments could actually damage 
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their quality of life” (J10, 4 years’ experience) 
Public and other journalists’ knowledge of 
harms 
“The understanding within general society and within the media of overdiagnosis is, I would think, low 
to non-existent.” (J15, 5 years’ experience) 
“I think there definitely needs to be more awareness of the issues around over diagnosis in the broader 
media community, cause I don’t think it’s a very well known issue. And if people don’t know about it 
they’re not going to include it in their stories.” (J2, 6 years’ experience) 
4. Factors influencing the framing of media coverage 
Press releases “They can be good in terms of directing you or tipping you off about new research or a certain expert 
in the area. But I usually take the, whatever comes out of a PR agency with a grain of salt” (J10, 4 
years’ experience) 
“Press releases, even sort of the Universities (laughs) and researchers are still making, you know, these 
massive mistakes and over-blowing research.” (J3, 9 years’ experience) 
Click-bait “You know, ‘breakthrough’ and ‘cure’ and those kind of very emotive words… people might want to 
click on those.” (J5, 22 years’ experience) 
“It doesn’t effect me at all. Because  don’t write for the outlets where that may, you know, my salary or 
my pay is conditional on clicks or click-throughs. But I think, yeah, click bait is a problem in all media, 
not just in health and medical.” (J1, 20 years’ experience) 
Commercial interests “Commercial partners that may be interested in getting the test out there, people who stand to benefit 
financially. So that’s a pressure out there. There are also maybe patient groups. I don’t know whether 
the patient groups share an agenda with people who are making a financial gain from the test or not?” 
(J4, 30 years’ experience) 
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“I think if I was approached by a pharmaceutical company with a new test they’ve developed I’d be 
very hesitant to write a story about it.” (J2, 6 years’ experience) 
Focus or good or bad news “Especially when it’s diseases that are, you know, really intractable or that people are really afraid of. 
I think it’s very easy to oversell things. It’s all about having a good story.” (J1, 20 years’ experience) 
Lack of training and experience “generalists don’t really have a background in health or science that are covering these things, not 
really getting to the bottom of where the money’s coming from?” (J3, 9 years’ experience) 
“I think especially beginner journalists or journalists who are just starting in the health round can 
approach topics uncritically” (J16, 9 years’ experience) 
5. Barriers to critical coverage of medical tests 
Journalist knowledge and experience “I think first and foremost when it comes to screening tests, I would say the knowledge around the 
potential pitfalls of screening or over screening is not well known or understood. I think that applies to 
the general population but I also think that probably applies to journalists as well.” (J6, 6 years’ 
experience) 
“I feel the core challenge is lack of knowledge. Like.. you know, I think you could speak to lots of health 
and science and just general news journalists and they would just have no idea that that was even a 
problem.You know, so I, I… and I, I reckon that their idea of it would probably as a percentage, you 
know, be in line with the general publics…… percentage of people who understood that there’s a 
problem. Like there just isn’t the literacy about this topic in the community or in the media.” (J15, 5 
years’ experience) 
Time pressures  “I think a really key barrier for most journalists is time. You’re often making decisions about coverage 
in that split second moment between like deleting or not deleting an email.” (J13, 6 years’ experience) 
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-043991:e043991. 11 2021;BMJ Open, et al. O'Keeffe M
“The main thing is time.  You can’t overstate it. And, and, yeah, the pressures of deadlines are just… 
constant and sometimes, yeah, unmanageable.” (J21, 4 years’ experience) 
 
Lack of access to experts “I didn’t end up covering it. But it was, it was a major issue because I spent at least a day trying to find 
someone, like a whole day trying to find someone to, who had the time, and, and the expertise, and I 
just couldn’t find them.” (J17, 12 years’ experience) 
“Just not perhaps having ready access to perhaps a group of reliable experts that can comment either 
on or off the record” (J18, 25 years’ experience) 
 
Complexity of overdiagnosis “So in a lot of ways that’s a message that’s been drummed into people for the last 30 years. You know, 
go and get, get a pap smear, go and get a mammogram, you know, go and get a bowel cancer test, and 
it comes in the mail. So that message of you need to be screened, you need to be getting a regular test 
has been something that’s been embedded in people’s minds. So it’s almost counterintuitive for them to 
think there’s a test there, why wouldn’t I have it?” (J12, 30 years’ experience) 
“Overdiagnosis sounds like a contradiction… because everybody wants a diagnosis. So how could 
having a diagnosis possibly be bad? Um… but yeah, we’re not very good at explaining it” (J8, 32 years’ 
experience) 
6. Enablers of critical coverage of medical tests 
Journalist training “Teach us how to read medical research, you know, how to tell if a publication is good or not.” (J2, 6 
years’ experience)  
“More journalism education in relation to evidence, types of evidence, statistics, all that kind of thing” 
(J4, 30 years’ experience) 
Training for academics and peak bodies ‘There’s work to do in educating some other sectors as well, like, you know, some of the, um… the 
medical colleges and the AMA and some of the other… medical and health groups that are called on to 
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comment on these stories” (J3, 9 years’ experience) 
“I think the onus is partly on… whoever is, um, providing recommendations around screening, whether 
that’s research institutes or not-for-profits advocacies, the health, government departments and so on.. 
that, you know, it would be pretty unusually I think to go on a website where there’s recommendations 
to screening that has a section about, um, when screening is not appropriate or, or the kind of pitfalls 
of over screening. I think that’s probably something that’s overlooked” (J6, 6 years’ experience) 
Better attempts to communicate harms “It would be worth groups like the group at Bond University, perhaps if they know research is coming 
out, or if they seen research is coming out, being a little bit reactive and putting out a media release of 
their own… yeah, I think, I think that a louder voice in the over diagnosis area would be, be fantastic.” 
(J2, 6 years’ experience) 
“There are powerful stories to be told about… people… the harms that are done…... from over testing 
and over treatments, and putting those stories out there would be, yeah, finding the stories and putting 
them out there would be… a good way to help bring some of those story tropes to the fore to make them 
more accessible to journalists.” (J4, 30 years’ experience) 
7. Interest in a training intervention “Yeah, I, I think it’s an excellent idea. And I think we should do it.” (J15, 5 years’ experience) 
 
“Yeah, look I think it would be great. Um, my favourite type of training personally is the ones where 
you do a lot of work shopping on stories.” (J4, 30 years’ experience) 
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